Press Releases DyDo Group Holdings, Inc.

Equities

Market Closed - Japan Exchange Other stock markets 11:30:00 28/06/2024 am IST			5-day change	1st Jan Change
2,678 ^JPY	-1.00%		-0.11%	-8.44%

31/05	DyDo Group Holdings, Inc. Reports Preliminary Sales Results for the Month from April 21, 2024 to May 20, 2024 and Year to Date from January 21, 2024 to May 20, 2024	CI
27/05	DyDo Group Holdings, Inc. Provides Dividend Guidance for the End of Second Quarter and Fiscal Year Ending January 20, 2025	CI

DyDo : Notice regarding recording of gains on the sale of investment securities (extraordinary profit)	17/22/17	PU
DyDo : Monthly Sales Report, July FY2022	25/22/25	PU
DyDo : Acquisition by a Consolidated Subsidiary of Marketing Licenses for Pharmaceuticals	15/22/15	PU
DyDo : Monthly Sales Report, June FY2022	27/22/27	PU
DyDo : Monthly Sales Report, May FY2022	25/22/25	PU
DyDo : Monthly Sales Report, April FY2022	25/22/25	PU
DyDo : Corporate Governance Report	18/22/18	PU
DyDo : Notice regarding disposal of treasury stock for restricted-stock-based compensation	15/22/15	PU
DyDo : Notice regarding Russian business policy	14/22/14	PU
DyDo : Overview of the Results of an Evaluation of the Effectiveness of the Board of Directors	15/22/15	PU
DyDo : Summary of Financial Results 2022	04/22/04	PU
DyDo : FY2021 Supplementary Material for Financial Results	04/22/04	PU
DyDo : FY2021 Financial Highlights	04/22/04	PU
DyDo : Monthly Sales Report, February FY2022	25/22/25	PU
DyDo : Revision to Consolidated Financial Forecasts for FY2021	15/22/15	PU
DyDo : Monthly Sales Report, January FY2021	25/22/25	PU
DyDo : Notice Concerning Formulation of the Mid-term Business Plan 2026	14/22/14	PU
DyDo : Notice Concerning Declaration of Support for Recommendations from the Task Force on Climate-related Financial Disclosures (TCFD)	14/22/14	PU
DyDo : Monthly Sales Report, December FY2021	27/21/27	PU
Catalyst Pharmaceuticals Announces DyDo Pharma Initiation of a Phase 3 Study for FIRDAPSE in Japan	07/21/07	AQ

No results for this search